← Back to all signals
RESEARCH PAPER ANALYSIS

The impact of alpha-fetoprotein (AFP), child-turcotte-pugh (CTP) score and disease staging on the survival of hepatocellular carcinoma (HCC) patients: a retrospective cohort from single oncology center.

AI interpretation is pending for this paper.

Open original publication →
PMID39735678
JournalOncology research
Publication Date2024-12-20
Ingested2026-08-02 12:03 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common cause of cancer-related death in Saudi Arabia. Our study aimed to investigate the patterns of HCC and the effect of TNM staging, Alfa-fetoprotein (AFP), and Child-Turcotte Pugh (CTP) on patients' overall survival (OS). METHODS: A retrospective analysis was conducted on 43 HCC patients at a single oncology center in Saudi Arabia from 2015 to 2020. All patients had to fulfill one of the following criteria: (a) a liver lesion reported as definitive HCC on dynamic imaging and/or (b) a biopsy-confirmed diagnosis. RESULTS: The mean patient age of all HCC cases was 66.8 with a male-to-female ratio of 3.3:1. All patients were stratified into two groups: viral HCC (n = 22, 51%) and non-viral HCC (n = 21, 49%). Among viral-HCC patients, 55% were due to HBV and 45% due to HCV. Cirrhosis was diagnosed in 79% of cases. Age and sex did not significantly statistically differ in OS among viral and non-viral HCC patients (p-value > 0.05). About 65% of patients had tumor size >5 cm during the diagnosis, with a significant statistical difference in OS (p-value = 0.027). AFP was >400 ng/ml in 45% of the patients. There was a statistically significant difference in the OS in terms of AFP levels (p-value = 0.021). A statistically significant difference was also observed between the CTP score and OS (p-value = 0.02). CTP class B had the longest survival. BSC was the most common treatment provided to HCC patients followed by sorafenib therapy. There was a significant statistical difference in OS among viral and non-viral HCC patients (p-value = 0.008). CONCLUSIONS: The most common predictors for OS were the underlying cause of HCC, AFP, and tumor size. Being having non-viral etiology, a tumor size >5 cm, an AFP > 400 ng/mL, and a CTP score class C were all negatively associated with OS.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Gastrointestinal manifestations in adult IgA vasculitis over 8.5 years: severity assessment and therapeutic outcomes. The Pan African medical journal 66.74 2 Using next-generation sequencing to clarify the parental RhD genotypes of a child with acute leukemia - A case report and review of the literature. Asian journal of transfusion science 45.5 3 Postoperative radiotherapy in pediatric versus adult head and neck malignancies: A two-center analysis of survival outcomes and age-specific late effects. Journal of cancer research and therapeutics 82.16 4 Infantile extragonadal germ cell tumors: Clinical characteristics, surgical outcomes, and healthcare delivery challenges at a rural tertiary care center in North India. Journal of cancer research and therapeutics 60.7 5 Clinicopathological characteristics of head and neck squamous cell carcinomas in adolescents and young adults: A retrospective hospital-based study from northeast India. Journal of cancer research and therapeutics 69.4 6 Epidemiological data of head and neck cancers from 2020 to 2025 in a tertiary cancer hospital-A retrospective study. Journal of cancer research and therapeutics 69.9 7 Secretory carcinoma of the breast - A rare case report. Journal of cancer research and therapeutics 45.5 8 Pneumocystis jirovecii Pneumonia in an Adolescent With Acute Lymphoblastic Leukemia Due to Non-adherence to Prophylaxis: A Case Report. Cureus 53.8 9 User Interface Designs to Address Cancer Misinformation: A Randomized Clinical Trial. JAMA network open 78.4 10 [Post-traumatic stress symptoms in parents of children with cancer: An exploratory study on the role of spousal support]. Sante mentale au Quebec 63.5 11 Pediatric oncology nurses' experiences with trauma-informed care in South Korea: a qualitative study. Child health nursing research 56.0 12 The diagnostic journey of fibrodysplasia ossificans progressiva: evidence from a national cohort of 114 patients. Frontiers in endocrinology 63.0 13 Barriers to survivorship care for adolescent and young adult cancer survivors: perspectives of survivors and cancer specialists. Frontiers in oncology 61.4 14 Divergent CMV and EBV co-infection impact in adult and pediatric hematopoietic stem cell transplantation recipients. Frontiers in cellular and infection microbiology 64.7 15 Sun protection during active travel on foot or by (e-)bike: an exploratory nationwide cross-sectional study from Germany. Frontiers in sports and active living 57.5 16 Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer. Frontiers in immunology 55.0 17 Beyond seizures: the hidden burden of developmental epileptic encephalopathies. Frontiers in neurology 63.0 18 LCK regulates apoptosis and intercellular communication networks in neuroblastoma. Biochemical and biophysical research communications 62.2 19 Divergent Trends and Widening Inequalities in Digestive Tract Cancers Among Women of Childbearing Age: A Global Analysis from 1990 to 2021 and Projections to 2050. International journal of women's health 40.5 20 Metabolic State Machines and Nutritional Ecology: A New Framework for Osteosarcoma Therapy. Drug design, development and therapy 64.84 21 Dynamics of IDH1 Mutation and Protein Expression Between Primary and Recurrent Gliomas and Their Prognostic Significance. Human mutation 63.3 22 Optimizing care for children with ovarian masses: development and evaluation of a multidisciplinary management algorithm. European journal of obstetrics, gynecology, and reproductive biology 73.9 23 Ex Vivo Thrombin Generation Assessment of Four Anticoagulants in Children with Acute Lymphoblastic Leukemia. Pediatric hematology and oncology 64.4 24 A Mobile Health Intervention to Reduce Sedentary Behavior Among Adolescents and Early Young Adults Receiving Treatment for Acute Lymphoblastic Leukemia: Protocol for a Single-Arm Feasibility Trial. JMIR research protocols 83.34 25 Cardiovascular Effects of Childhood Radiotherapy. Cardiology in review 66.54 26 Clinical risk features and genetic findings in essential thrombocythemia and polycythemia vera of childhood and adolescence: prospective insights from the German MPN Childhood Registry. Haematologica 61.9 27 Standard treatment against paediatric BRAF-V600E glioma promotes senescence and sensitizes tumours to BCL-xL inhibition. Neuro-oncology 62.94 28 Lorlatinib-Containing Therapy for MYCN-Amplified, ALK-Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report. Pediatric blood & cancer 54.76 29 Infantile posterior fossa atypical teratoid/rhabdoid tumor: navigating diagnostic complexity and molecular paradigms. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 58.4 30 Changing Prescriptions May Distort Nutritional Adherence Associations in Children with Cancer. Nutrition and cancer 47.5 31 Surgical treatment of tailgut cysts: a single-center analysis of 19 cases. Langenbeck's archives of surgery 66.14 32 "Food is like all we do all day": a qualitative exploration of nutritional challenges and intervention needs among families of early childhood cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 61.1
PATIENT-FRIENDLY SUMMARY

The impact of alpha-fetoprotein (AFP), child-turcotte-pugh (CTP) score and disease staging on the survival of hepatocellular carcinoma (HCC) patients: a retrospective cohort from single oncology center.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic